The methylation requirement gives DpnI restriction its selectivity: the enzyme acts on GATC sites when the adenine carries methylation in a methylated or hemimethylated context. An unmethylated PCR product therefore avoids the same cleavage pattern. This molecular difference converts DNA methylation status into a practical way to separate parental and newly synthesized molecules.
Recognition of hemimethylated GATC sites broadens the set of parental DNA molecules that can be targeted. DNA with methylation on only one strand can still qualify as a DpnI substrate, whereas the unmethylated amplified product does not share that substrate state. This distinction enables the method to discriminate templates based on their propagation history.
DNA propagated in many bacterial strains commonly carries the methylation pattern that DpnI recognizes. Consequently, the starting plasmid can be marked for enzymatic removal before recovery of the engineered product. The relevant variable is not simply whether DNA is plasmid or PCR-derived, but whether its GATC sites retain the recognized methylation state.
Following site-directed mutagenesis PCR, the reaction is treated with DpnI so the methylated parental plasmid is cleaved. The amplified DNA carrying the intended sequence change remains available for recovery because it lacks the recognized methylation state. This sequence of amplification followed by selective digestion streamlines isolation of engineered plasmids for subsequent biology experiments.
The main outcome is selective depletion of the parental template. Because parental DNA is digested while the unmethylated amplification product remains, recovery is directed toward engineered plasmids rather than the original template. This enrichment streamlines the transition from mutagenesis PCR to gene editing, protein expression studies, or functional analysis of the altered sequence.
Recovered engineered plasmids can carry defined DNA sequence changes into several research settings. In gene editing, the method helps separate altered products from the starting plasmid; in protein expression studies, it supports obtaining engineered plasmids for expression work; and in functional analysis, it facilitates evaluation of DNA sequence changes. Its shared value is cleaner recovery of designed DNA.